RSAD2 and neoplasm: The results revealed that immRNA‐loaded RBCEVs treatment activated the RIG‐I pathway by up‐regulating DDX58, MDA5, RSAD2, MAVS, IRF3, IRF7, IFNB, and ISG56 in the tumour cells (Figure S4G).